Cdw52-specific antibody for treatment of multiple sclerosis

Details Cdw52-specific antibody for treatment of multiple sclerosis Cdw52-specific antibody for treatment of multiple sclerosis

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/57 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2124964

The invention relates to the use of an antibody recognising the CDw52 antigen in the treatment of multiple sclerosis. Preferably the antibody is the humanised antibody in the humanised antibody CAMPATH-1H.

Affiliated with

Also associated with

Rating

Cdw52-specific antibody for treatment of multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cdw52-specific antibody for treatment of multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cdw52-specific antibody for treatment of multiple sclerosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1885709